The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs hospital

Infection Control and Hospital Epidemiology

Volumn 21, Issue 7, 2000, Pages 459-464

  Vasquez, Jose E ^a   Walker, Elaine S ^a   Franzus, Bettylene W ^a   Overbay, Barbara K ^a   Reagan, David R ^a   Sarubbi, Felix A ^a,b  

^a E Tennessee Stt Univ Coll Med   (United States)

^b East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSEUDOMONIC ACID;

ADULT; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; ENDEMIC DISEASE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NURSING HOME; OUTPATIENT; PULSED FIELD GEL ELECTROPHORESIS; RISK ASSESSMENT; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 0033865192     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/501788     Document Type: Article

References (27)

1. Boyce JM. Methicillin-resistant Staphylococcus aureus in hospitals and long-term care facilities: microbiology, epidemiology, and preventive measures. Infect Control Hosp Epidemiol 1992;13:725-737.
2. Mulligan ME, Murray-Leisure KA, Ribner BS, Standiford HC, John JF, Korvick JA, et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993;94:313-328.
3. Muder RR, Brennen C, Wagener MM, Vickers RM, Rihs JD, Hancock GA, et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med 1991;114:107-112.
4. Spindel SJ, Strausbaugh LJ, Jacobson C. Infections caused by Staphylococcus aureus in a Veterans' Affairs nursing home care unit: a 15-year experience. Infect Control Hosp Epidemiol 1995;16:217-223.
5. Meier PA, Carter CD, Wallace SE, Hollis RJ, Pfaller MA, Herwaldt LA. A prolonged outbreak of methicillin-resistant Staphylococcus aureus in the burn unit of a tertiary medical center. Infect Control Hosp Epidemiol 1996;17:798-802.
6. Nicolle LE, Dyck B, Thompson G, Roman S, Kabani A, Plourde P, et al. Regional dissemination and control of epidemic methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 1999;20:202-205.
7. Murray-Leisure KA, Geib S, Graceley D, Rubin-Slutsky AB, Saxena N, Muller HA, et al. Control of epidemic methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 1990;11:343-350.
8. Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998;27:543-550.
9. Reagan DR, Doebbling BN, Pfaller MA Sheetz CT, Houston AK, Hollis RJ, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin ointment. Ann Intern Med 1991;114:101-106.
10. Bradley SF. Effectiveness of mupirocin in the control of methicillin-resistant Staphylococcus aureus. Infect Med 1993;10:23-31.
11. Kauffman CA, Terpenning MS, He X, Zarins LT, Ramsey MA, Jorgensen KA, et al. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment. Am J Med 1993;94:371-378.
12. Bradley SF, Ramsey MA, Morton TM, Kauffman CA. Mupirocin resistance: clinical and molecular epidemiology. Infect Control Hosp Epidemiol 1995;16:354-358.
13. Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996;17:811-813.
14. Santos KRN, Fonseca LS, Filho PPG. Emergence of high level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian university hospitals. Infect Control Hosp Epidemiol 1996;17:813-816.
15. Kavi J, Andrews JM, Wise R. Mupirocin resistant Staphylococcus aureus. Lancet 1987;2:1472.
16. Rahman M, Noble WC, Cookson B. Mupirocin resistant Staphylococcus aureus. Lancet 1987;2:387.
17. Neu HC. The use of mupirocin in controlling methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 1990;11:11-12.
18. Fuchs PC, Jones RN, Barry AL. Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic. J Clin Microbiol 1990;28:608-609.
19. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobieally. Approved standard. 4th ed. Vol 17, No. 2. Villanova, PA; 1997:M7A4.
20. Gilbart J, Perry CR, Slocombe B. High level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases. Antimicrob Agents Chemother 1993;37:32-38.
21. Morton TM, Johnston JL, Patterson J, Archer GL. Characterization of a conjugative staphylococcal mupirocin resistance plasmid. Antimicrob Agents Chemother 1995;39:1272-1280.
22. Maslow JN, Slutsky AM, Arbeit RD. Application of pulsed-field electrophoresis to molecular epidemiology. In: Persing DH, Smith TF, White TJ, eds. Diagnostic Molecular Microbiology Principles and Practice. Washington, DC: American Society for Microbiology; 1993:563-572.
23. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed field gelelectrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239.
24. Gaynes RP, Horan TC. Surveillance of nosocomial infections. In: Mayhall CG, ed. Hospital Epidemiology and Infection Control. Philadelphia, PA: Lippincott Williams & Wilkins; 1999:1296-1307.
25. Hodgson JE, Curnock SP, Dyke KGH, Morris R, Sylvester DR, Gross MS. Molecular characterization of the gene encoding high-level mupirocin resistance in Stapkylococcus aureus J2870. Antimicrob Agents Chemother 1994;38:1205-1208.
26. Boyce JM. Should we vigorously try to contain and control methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 1991;12:46-54.
27. Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, double blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999;43:1412-1416.